LONDON, Jan 28 (Reuters) - British Prime Minister Boris
Johnson said on Thursday that it was good news the Novavax
vaccine for COVID-19 had proved effective in trials in
the United Kingdom.
"Our medicines regulator will now assess the vaccine, which
will be made in Teesside. If approved, we have 60m (million)
doses on order," Johnson said on Twitter.
(Writing by William Schomberg; Editing by Leslie Adler)